Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
1.
Braz. j. microbiol ; 46(3): 861-865, July-Sept. 2015. tab, ilus
Article Dans Anglais | LILACS | ID: lil-755806

Résumé

Newcastle disease vaccines hitherto in vogue are produced from embryonated chicken eggs. Egg-adapted mesogenic vaccines possess several drawbacks such as paralysis and mortality in 2-week-old chicks and reduced egg production in the egg-laying flock. Owing to these possible drawbacks, we attempted to reduce the vaccine virulence for safe vaccination by adapting the virus in a chicken embryo fibroblast cell culture (CEFCC) system. Eighteen passages were carried out by CEFCC, and the pathogenicity was assessed on the basis of the mean death time, intracerebral pathogenicity index, and intravenous pathogenicity index, at equal passage intervals. Although the reduction in virulence demonstrated with increasing passage levels in CEFCC was encouraging, 20% of the 2-week-old birds showed paralytic symptoms with the virus vaccine from the 18th(final) passage. Thus, a tissue-culture-adapted vaccine would demand a few more passages by CEFCC in order to achieve a complete reduction in virulence for use as a safe and effective vaccine, especially among younger chicks. Moreover, it can be safely administered even to unprimed 8-week-old birds.

.


Sujets)
Animaux , Embryon de poulet , Poulets/virologie , Virus de la maladie de Newcastle/pathogénicité , Maladies de la volaille/prévention et contrôle , Vaccins atténués/usage thérapeutique , Vaccins antiviraux/usage thérapeutique , Techniques de culture cellulaire , Cellules cultivées , Poulets/immunologie , Virus de la maladie de Newcastle/classification , Virus de la maladie de Newcastle/croissance et développement , Culture de cellules primaires , Maladies de la volaille/immunologie , Maladies de la volaille/virologie , Vaccination , Vaccins atténués/effets indésirables , Vaccins atténués/immunologie , Vaccins antiviraux/effets indésirables , Vaccins antiviraux/immunologie
2.
Journal of Veterinary Science ; : 37-46, 2015.
Article Dans Anglais | WPRIM | ID: wpr-206914

Résumé

Toll-like receptor 5 (TLR5) is responsible for the recognition of bacterial flagellin in vertebrates. In the present study, the first TLR5 gene in duck was cloned. The open reading frame (ORF) of duck TLR5 (dTLR5) cDNA is 2580 bp and encodes a polypeptide of 859 amino acids. We also cloned partial sequences of myeloid differentiation factor 88, 2'-5'-oligoadenylate synthetase (OAS), and myxovirus resistance (Mx) genes from duck. dTLR5 mRNA was highly expressed in the bursa of Fabricius, spleen, trachea, lung, jejunum, rectum, and skin; moderately expressed in the muscular and glandular tissues, duodenum, ileum, caecum, and pancreas; and minimally expressed in the heart, liver, kidney, and muscle. DF-1 or HeLa cells transfected with DNA constructs encoding dTLR5 can activate NF-kappaB leading to the activation of interleukin-6 (IL-6) promoter. When we challenged ducks with a Herts33 Newcastle disease virus (NDV), mRNA transcription of the antiviral molecules Mx, Double stranded RNA activated protein kinase (PKR), and OAS was up-regulated in the liver, lung, and spleen 1 and 2 days post-inoculation.


Sujets)
Animaux , Humains , 2',5'-Oligoadenylate synthetase/génétique , Lignée cellulaire , Clonage moléculaire , Canards , Régulation de l'expression des gènes/physiologie , Immunité innée , Facteur de différenciation myéloïde-88/génétique , Protéines de résistance aux myxovirus/génétique , Maladie de Newcastle/métabolisme , Virus de la maladie de Newcastle/classification , ARN messager/génétique , Spécificité d'espèce , Récepteur de type Toll-5/génétique
SÉLECTION CITATIONS
Détails de la recherche